Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

Cited In for PubMed (Select 17320118)

1.

Cannabinoids in experimental stroke: a systematic review and meta-analysis.

England TJ, Hind WH, Rasid NA, O'Sullivan SE.

J Cereb Blood Flow Metab. 2015 Mar;35(3):348-358. doi: 10.1038/jcbfm.2014.218. Epub 2014 Dec 10. Review.

PMID:
25492113
2.

Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Miljković D, Spasojević I.

Antioxid Redox Signal. 2013 Dec 20;19(18):2286-334. doi: 10.1089/ars.2012.5068. Epub 2013 Apr 22. Review.

3.

Is the cardiovascular system a therapeutic target for cannabidiol?

Stanley CP, Hind WH, O'Sullivan SE.

Br J Clin Pharmacol. 2013 Feb;75(2):313-22. doi: 10.1111/j.1365-2125.2012.04351.x. Review.

4.

Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?

Fernández-Ruiz J, Sagredo O, Pazos MR, García C, Pertwee R, Mechoulam R, Martínez-Orgado J.

Br J Clin Pharmacol. 2013 Feb;75(2):323-33. doi: 10.1111/j.1365-2125.2012.04341.x. Review.

5.

Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus.

Rock EM, Bolognini D, Limebeer CL, Cascio MG, Anavi-Goffer S, Fletcher PJ, Mechoulam R, Pertwee RG, Parker LA.

Br J Pharmacol. 2012 Apr;165(8):2620-34. doi: 10.1111/j.1476-5381.2011.01621.x.

6.

Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients.

Bergamaschi MM, Queiroz RH, Chagas MH, de Oliveira DC, De Martinis BS, Kapczinski F, Quevedo J, Roesler R, Schröder N, Nardi AE, Martín-Santos R, Hallak JE, Zuardi AW, Crippa JA.

Neuropsychopharmacology. 2011 May;36(6):1219-26. doi: 10.1038/npp.2011.6. Epub 2011 Feb 9.

7.

Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion.

Walsh SK, Hepburn CY, Kane KA, Wainwright CL.

Br J Pharmacol. 2010 Jul;160(5):1234-42. doi: 10.1111/j.1476-5381.2010.00755.x.

8.

Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors.

Zanelati TV, Biojone C, Moreira FA, Guimarães FS, Joca SR.

Br J Pharmacol. 2010 Jan;159(1):122-8. doi: 10.1111/j.1476-5381.2009.00521.x. Epub 2009 Dec 4.

9.

Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice.

Capasso R, Borrelli F, Aviello G, Romano B, Scalisi C, Capasso F, Izzo AA.

Br J Pharmacol. 2008 Jul;154(5):1001-8. doi: 10.1038/bjp.2008.177. Epub 2008 May 12.

10.

Cannabinoid control of neuroinflammation related to multiple sclerosis.

Baker D, Jackson SJ, Pryce G.

Br J Pharmacol. 2007 Nov;152(5):649-54. Epub 2007 Sep 24. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk